Cargando…
Thalamotomy for essential tremor: FDA approval brings brain treatment with FUS to the clinic
Autor principal: | Fishman, Paul S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508673/ https://www.ncbi.nlm.nih.gov/pubmed/28717511 http://dx.doi.org/10.1186/s40349-017-0096-9 |
Ejemplares similares
-
Treatment-Specific Network Modulation of MRI-Guided Focused Ultrasound Thalamotomy in Essential Tremor: Modulation of ET-Related Network by MRgFUS Thalamotomy
por: Xiong, Yongqin, et al.
Publicado: (2022) -
Evaluation of Cerebral Volume Changes in Patients with Tremor Treated by MRgFUS Thalamotomy
por: Bruno, Federico, et al.
Publicado: (2022) -
Thalamic Tremor Following Focused Ultrasound Thalamotomy for the Treatment of Essential Tremor
por: Osterholt, Thomas, et al.
Publicado: (2020) -
MRgFUS thalamotomy for the treatment of tremor: evaluation of learning curve and operator’s experience impact on the procedural and clinical outcome
por: Bruno, F., et al.
Publicado: (2023) -
Cerebello-Thalamo-Cortical MR Spectroscopy in Patients with Essential Tremor Undergoing MRgFUS Thalamotomy: A Pilot Study
por: Bruno, Federico, et al.
Publicado: (2022)